Retrospective return on investment analysis of the SIMpill treatment adherence device piloted at Betty Gaetsewe clinic in the Northern Cape

Sean Broomhead, Maurice Mars


The proposed research will compare the cost benefit (and return on investment) between implementing the SIMpill real-time electronic treatment adherence support device to support patients suffering from Pulmonary Tuberculosis in a small town in the Northern Cape Province with the cost benefit of more conventional DOTS treatment adherence support.


The retrospective analysis will utilise the Cost-Effects-Utility-Benefits model of Drummond et. al to compare the cost return on investment of patients who participated in the SIMpill device pilot in 2005 with a matched cohort of patients who were supported by more conventional DOTS treatment adherence support.